223 related articles for article (PubMed ID: 20796312)
1. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.
Zilberberg MD; Chen J; Mody SH; Ramsey AM; Shorr AF
BMC Pulm Med; 2010 Aug; 10():45. PubMed ID: 20796312
[TBL] [Abstract][Full Text] [Related]
2. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
[TBL] [Abstract][Full Text] [Related]
3. Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia.
Luyt CE; Aubry A; Lu Q; Micaelo M; Bréchot N; Brossier F; Brisson H; Rouby JJ; Trouillet JL; Combes A; Jarlier V; Chastre J
Antimicrob Agents Chemother; 2014; 58(3):1372-80. PubMed ID: 24342638
[TBL] [Abstract][Full Text] [Related]
4. Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
Kollef MH; Nathwani D; Merchant S; Gast C; Quintana A; Ketter N
Crit Care; 2010; 14(3):R84. PubMed ID: 20459721
[TBL] [Abstract][Full Text] [Related]
5. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia.
Zilberberg MD; Mody SH; Chen J; Shorr AF
Surg Infect (Larchmt); 2010 Oct; 11(5):409-17. PubMed ID: 20666580
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.
Kallel H; Hergafi L; Bahloul M; Hakim A; Dammak H; Chelly H; Hamida CB; Chaari A; Rekik N; Bouaziz M
Intensive Care Med; 2007 Jul; 33(7):1162-1167. PubMed ID: 17530220
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials.
Jenkins SG; Fisher AC; Peterson JA; Nicholson SC; Kaniga K
Curr Med Res Opin; 2009 Dec; 25(12):3029-36. PubMed ID: 19849650
[TBL] [Abstract][Full Text] [Related]
9. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
Tennenberg AM; Davis NB; Wu SC; Kahn J
Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence.
Crandon JL; Luyt CE; Aubry A; Chastre J; Nicolau DP
J Antimicrob Chemother; 2016 Sep; 71(9):2534-7. PubMed ID: 27272723
[TBL] [Abstract][Full Text] [Related]
11. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.
Tran GM; Ho-Le TP; Ha DT; Tran-Nguyen CH; Nguyen TSM; Pham TTN; Nguyen TA; Nguyen DA; Hoang HQ; Tran NV; Nguyen TV
BMC Infect Dis; 2017 Jun; 17(1):429. PubMed ID: 28619105
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa.
Furtado GH; Gales AC; Perdiz LB; Santos AF; Medeiros EA
Rev Soc Bras Med Trop; 2011 Oct; 44(5):604-6. PubMed ID: 22031077
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
Planquette B; Timsit JF; Misset BY; Schwebel C; Azoulay E; Adrie C; Vesin A; Jamali S; Zahar JR; Allaouchiche B; Souweine B; Darmon M; Dumenil AS; Goldgran-Toledano D; Mourvillier BH; Bédos JP;
Am J Respir Crit Care Med; 2013 Jul; 188(1):69-76. PubMed ID: 23641973
[TBL] [Abstract][Full Text] [Related]
14. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
15. Nebulized imipenem to control nosocomial pneumonia caused by Pseudomonas aeruginosa.
Radhakrishnan M; Jaganath A; Rao GS; Kumari HB
J Crit Care; 2008 Mar; 23(1):148-50. PubMed ID: 18359432
[No Abstract] [Full Text] [Related]
16. Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patients.
Reinhardt A; Köhler T; Wood P; Rohner P; Dumas JL; Ricou B; van Delden C
Antimicrob Agents Chemother; 2007 Apr; 51(4):1341-50. PubMed ID: 17261619
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
Sader HS; Castanheira M; Flamm RK
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
[TBL] [Abstract][Full Text] [Related]
19. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.
Carmeli Y; Lidji SK; Shabtai E; Navon-Venezia S; Schwaber MJ
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):367-72. PubMed ID: 21683268
[TBL] [Abstract][Full Text] [Related]
20. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
